Meeting Coverage
EASD
European Association for the Study of Diabetes
Latest EASD Meeting Coverage
The faster formulation led to fewer hypoglycemia events versus conventional insulin aspart
However, no FDA-approved systems have a pregnancy indication yet
EMERGE trial misses on primary endpoint, but secondary outcomes suggest potential benefit
Results with the GIP/GLP-1 receptor agonist were statistically superior to added insulin lispro
Data support looking at enterovirus vaccination for prevention
Systematic review indicates vast sex differences in youth with type 1 diabetes
Other groups at risk for early mortality include smokers, those diagnosed at younger ages
Preservation of ovaries played into this association
Study found significant corneal nerve damage even before full-blown type 2 diabetes
A roundup of noteworthy research from the EASD 2021 meeting
Clues from post-hoc analysis of the REWIND trial
Age, worse overall health at operation time appear to play a part
Study finds association between alendronate use and future diabetes risk
Maintaining control of risk factors neutralized excess dementia risk
Latest Endocrinology Meeting Coverage
-
EASD: European Association for the Study of Diabetes
September 2024
-
ENDO: The Endocrine Society
June 2024
-
AACE: American Association of Clinical Endocrinology
May 2024
-
Obesity Week: The Obesity Society
October 2023